Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CryoDAO is a DeSci DAO focused on cryopreservation research. Its goal is to provide funding and community support for scientific projects that could improve the quality and capabilities of cryopreservation. According to its website, it has a treasury of over $5 million, a market cap of around $1.5 million, and 6,000+ community members, and has already funded multiple projects in areas such as multi-organ preservation, whole-ovary vitrification and reimplantation, and the construction of cryopreservation facilities.
In terms of platform type, CryoDAO is closer to a research funding DAO than an exchange, wallet, or conventional DeFi protocol. The text mentions the CRYO Token, and in the STASIS project it states that STASIS is a governance token used to govern American Biostasis DAO and the selection of projects within its laboratory. As for supported assets, only CRYO, STASIS, HYDRA, and USDC can be confirmed from the available information, while the chain, contract addresses, trading pairs, and sources of liquidity are not disclosed. Fees, KYC requirements, cold wallets, insurance, audits, and similar information are also not mentioned in the text.
CryoDAO’s “pricing” is not based on a subscription model. Instead, it supports research through its DAO treasury, donations, and token-based financing. The STASIS project states that CryoDAO and HydraDAO are each requesting 100,000 USDC in early-stage funding, and that it plans to raise a total of about $4.45 million through donations and a STASIS token sale for construction, laboratories, a CT scanner, medical equipment, and other needs. The acquisition cost, exchange method, and fees for CRYO itself are not disclosed.
Its strengths are its highly specialized positioning and relatively rich project documentation. Some projects disclose funding amounts, researchers, scientific reviews, and progress updates, giving CryoDAO better transparency than many DAOs that remain purely conceptual. Its ecosystem partners include VitaDAO, Tomorrow Bio, European Biostasis Foundation, and others, giving it a degree of DeSci network effect. The downside is that information most relevant to crypto users—such as tokenomics, secure custody, compliance, KYC, and secondary-market liquidity—is insufficient, while scientific outcomes also involve long timelines and high uncertainty.
CryoDAO is better suited to users interested in cryopreservation, longevity technology, DeSci governance, and research funding. It is not suitable as a tool for trading, yield generation, or leverage. Access from China is not disclosed in the text, and network availability, payment methods, and restrictions on participation in token sales are all unknown. If users simply want to trade mainstream crypto assets, they should prioritize compliant trading platforms; if they are interested in DeSci, they may compare CryoDAO with VitaDAO, Beaker DAO, or HydraDAO.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cryodao.org official site.
cryodao.org is an United States Crypto provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach cryodao.org directly.